Abstract
Starting from the definitions of the basic modifier mechanisms, extensions to more complex systems are not always straightforward but can be achieved if the underlying theories are well understood and used correctly. The mathematical aspects can become more complex but the labor is compensated by rewarding results. This chapter fulfills a double purpose by showing the way for managing system of increasing complexity illustrating the theory with practical examples, and by adding methods that complement those described in the preceding chapters.
⋯ readers who understand the methods used to discriminate between the simple cases are well equipped to adapt them to special experimental circumstances and to understand the more detailed discussions found elsewhere.
A. Cornish-Bowden (2012) Fundamentals of Enzyme Kinetics, Wiley-Blackwell. p. 190
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
It is important to remember that this is mere formalism because whenever a reagent is present in excess, its concentration is part of the equilibrium constant of the reaction and can by no means be omitted.
- 2.
To avoid confusion, the microscopic constants are numbered respecting the topology of reaction schemes already used in the preceding chapters by adding the new constant k 8.
- 3.
Readers interested in the cited papers published by Di Cera and collaborators should note that the authors use association constants in place of dissociation constants as in this book.
- 4.
This sound advice seems to have been largely ignored.
- 5.
Acronym of [2-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethylamino]-2-oxoethyl] 2-(furan-2- carbonylamino)acetate.
- 6.
Abz = ortho-aminobenzoyl; Dnp = N\(\varepsilon\)-2,4-dinitrophenyl; the arrow indicates the scissile bond.
References
Ackermann WW, Potter VR (1949) Enzyme inhibition in relation to chemotherapy. Proc Soc Exp Biol Med 72:1–9
Ayala Y, Di Cera E (1994) Molecular recognition by thrombin. Role of the slow to fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J Mol Biol 235:733–746. doi:10.1006/jmbi.1994.1024
Baici A (1987) Graphical and statistical analysis of hyperbolic, tight-binding inhibition [This paper contains a mathematical mistake: see correction in Szedlacsek, S. et al. (1988) Biochem. J. 254:311–312]. Biochem J 244:793–796
Cha S (1975) Tight-binding inhibitors - I. Kinetic behavior [See corrections, ibid. 25 (1976) 1561]. Biochem Pharmacol 24:2177–2185
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cleland WW (1963) The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. Biochim Biophys Acta 67:104–136
Cornish-Bowden A (1974) A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J 137:143–144
Cornish-Bowden A (2012) Fundamentals of enzyme kinetics, 4th edn. Wiley, Weinheim
Cortés A, Cascante M, Cárdenas ML, Cornish-Bowden A (2001) Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 357:263–268
Cotrin SS, Puzer L, Judice WAD, Juliano L, Carmona AK, Juliano MA (2004) Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem 335:244–252
Cristofaro RD, Di Cera E (1990) Effect of protons on the amidase activity of human α-thrombin: analysis in terms of a general linkage scheme. J Mol Biol 216:1077–1085. http://dx.doi.org/10.1016/S0022-2836(99)80021-7
Di Cera E, Cristofaro RD, Albright DJ, Fenton JW (1991) Linkage between proton binding and amidase activity in human.alpha.-thrombin: effect of ions and temperature. Biochemistry 30:7913–7924. doi:10.1021/bi00246a007
Di Cera E, Dang QD, Ayala Y, Vindigni A (1995) Linkage at steady state: allosteric transitions of thrombin. Meth Enzymol 259:127–144
Di Cera E, Hopfner KP, Dang QD (1996) Theory of allosteric effects in serine proteases. Biophys J 70:174–181
Henderson PJF (1972) A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J 127:321–333
Hill AV (1910) The possible effect of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40:4–7
Koshland DE, Némethy G, Filmer D (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5:365–385
Küçükkilinç T, Özer I (2005) Inhibition of human plasma cholinesterase by malachite green and related triarylmethane dyes: mechanistic implications. Arch Biochem Biophys 440:118–122. http://dx.doi.org/10.1016/j.abb.2005.06.003
Küçükkilinç T, Özer I (2007) Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes. Arch Biochem Biophys 461:294–298
Lenarčič B, Bevec T (1998) Thyropins: new structurally related proteinase inhibitors. Biol Chem 379:105–111
Lenarčič B, Turk V (1999) Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J Biol Chem 274:563–566
Lenarčič B, Ritonja A, Strukelj B, Turk B, Turk V (1997) Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. J Biol Chem 272:13899–13903
Liu HY, Wang Z, Regni C, Zou X, Tipton PA (2004) Detailed kinetic studies of an aggregating inhibitor; inhibition of phosphomannomutase/phosphoglucomutase by disperse blue 56. Biochemistry 43:8662–8669. doi:10.1021/bi0491907
Ludewig S, Kossner M, Schiller M, Baumann K, Schirmeister T (2010) Enzyme kinetics and hit validation in fluorimetric protease assays. Curr Top Med Chem 10:368–382
McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45:1712–1722
McGovern SL, Helfand BT, Feng B, Shoichet BK (2003) A specific mechanism of nonspecific inhibition. J Med Chem 46:4265–4272
Monod J, Changeux JP, Jacob F (1963) Allosteric proteins and cellular control systems. J Mol Biol 6:306–329
Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88–118
Morrison JF (1969) Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. Biochim Biophys Acta 185:269–286
Naqui A (1983) What does I50 mean? Biochem J 215:429–430
Palmier MO, Doren SRV (2007) Rapid determination of enzyme kinetics from fluorescence: Overcoming the inner filter effect. Anal Biochem 371:43–51
Schechter I, Berger A (1967) On the size of the active sites in proteases. I. Papain. Biochem Biophys Res Commun 27:157–162
Schenker P, Alfarano P, Kolb P, Caflisch A, Baici A (2008) A double-headed cathepsin B inhibitor devoid of warhead. Protein Sci 17:2145–2155
Segel IH (1975) Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York
Shoichet BK (2006) Interpreting steep dose-response curves in early inhibitor discovery. J Med Chem 49:7274–7277
Shoichet BK (2006) Screening in a spirit haunted world. Drug Discov Today 11:607–615
Straus OH, Goldstein A (1943) Zone behavior of enzymes. Illustrated by the effect of dissociation constant and dilution on the system cholinesterase-physostigmine. J Gen Physiol 26:559–585
Szedlacsek SE, Ostafe V, Serban M, Vlad MO (1988) A re-evaluation of the kinetic equations for hyperbolic tight-binding inhibition. Biochem J 254:311–312
Taketa K, Pogell BM (1965) Allosteric inhibition of rat liver fructose 1,6-diphosphatase by adenosine 5’-monophosphate. J Biol Chem 240:651–662
Wells CM, Di Cera E (1992) Thrombin is a Na+-activated enzyme. Biochemistry 31:11721–11730. doi:10.1021/bi00162a008
Xing GW, Li XW, Tian GL, Ye YH (2000) Enzymatic peptide synthesis in organic solvent with different zeolites as immobilization matrixes. Tetrahedron 56:3517–3522. doi:10.1016/S0040-4020(00)00261-1
Author information
Authors and Affiliations
Appendix
Appendix
4.1.1 Derivation of the Tight-Binding Rate Equation for the General Modifier Mechanism
Redirected from Sect. 4.4. The reactant concentrations in a rate equation represent free concentrations. However, in the presence of tight-binding, disambiguation between free and total concentrations is made by appending a ‘t’ (total), and where necessary an ‘f’ (free) to the symbols of concentration. We start the derivation of the tight-binding rate equation of the general modifier mechanism by putting in evidence the free modifier concentration while rearranging (3.35) discussed in Chap. 3
from which \(\left [\mathrm{X}\right ]_{\mathrm{f}}\) can be extracted as:
To proceed, an expression of the total modifier concentration is needed as the sum \(\left [\mathrm{EX}\right ] + \left [\mathrm{ESX}\right ] + \left [\mathrm{X}\right ]_{\mathrm{f}}\), and \(\left [\mathrm{EX}\right ] + \left [\mathrm{ESX}\right ]\) can be obtained considering the rate (4.51) at saturating modifier, in which case all enzyme molecules are present in these two complexes with product generation occurring only by decomposition of ESX into EX + P:
The denominator of (4.53) represents now EX + ESX, while the denominator of (4.51) represents \(\mathrm{E} + \mathrm{ES} + \mathrm{EX} + \mathrm{ESX}\). According to the distribution equations of Cleland [6], dividing the first by the second of these denominators and multiplying by \(\left [\mathrm{X}\right ]_{\mathrm{f}}\left [\mathrm{E}\right ]_{\mathrm{t}}\) yields \(\left [\mathrm{EX}\right ] + \left [\mathrm{ESX}\right ]\):
Experimentally, rates are measured which contain the concentrations of the complexes. Thus, such concentrations must be deduced from the differences between the rate in the absence (\(v_{0}\)) of modifier, at a given modifier concentration (\(v_{\mathrm{X}}\)) and at saturating modifier (\(v_{\infty }\)), i.e., \(\left (v_{0} - v_{\mathrm{X}}\right )\) and \(\left (v_{0} - v_{\infty }\right )\) using the explicit expression \(v_{0} = V \sigma \left /\right. \left (1+\sigma \right )\), (4.51) and (4.53):
After multiplication by \(\left [\mathrm{E}\right ]_{\mathrm{t}}\), the ratio in (4.55) is identical with (4.54) and the sought conservation equation for the modifier concentration becomes:
We have now all elements for writing the rate equation of the general modifier mechanism under tight-binding conditions but it would contain \(v_{\infty }\), which can be usefully replaced by other parameters to produce an expression that contains only familiar elements present in (4.51) and in the specific velocity equation (3.36). Inspection of (4.53) suggest the following, equivalent rearrangement obtained by multiplying the numerator and the denominator by α K X:
Furthermore, purposeful rearrangement of (4.52) gives
where the term underscored by the curled brace represents \(v_{\infty }\) in (4.57).
The conservation equation for the modifier’s concentration is finally obtained introducing (4.51), (4.57), and (4.58) in (4.56). The resulting expression is then used to extract \(v_{\mathrm{X}}\), a quadratic equation, whose physically significant root is displayed as (4.35) in the main text.
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Baici, A. (2015). Complements to Enzyme–Modifier Interactions. In: Kinetics of Enzyme-Modifier Interactions. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1402-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1402-5_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1401-8
Online ISBN: 978-3-7091-1402-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)